These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20179647)

  • 1. Rapid progression of NASH in childhood.
    Kohli R; Boyd T; Lake K; Dietrich K; Nicholas L; Balistreri WF; Ebach D; Shashidhar H; Xanthakos SA
    J Pediatr Gastroenterol Nutr; 2010 Apr; 50(4):453-6. PubMed ID: 20179647
    [No Abstract]   [Full Text] [Related]  

  • 2. TNF-alpha as therapeutic target in NASH: tried, but not yet proven.
    Chitturi S; Farrell GC
    J Gastroenterol Hepatol; 2007 May; 22(5):613-4. PubMed ID: 17444846
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonalcoholic steatohepatitis: a study of 49 patients.
    Lee RG
    Hum Pathol; 1989 Jun; 20(6):594-8. PubMed ID: 2656500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty liver hepatitis and cirrhosis in obese patients.
    Adler M; Schaffner F
    Am J Med; 1979 Nov; 67(5):811-6. PubMed ID: 507094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic steatohepatitis.
    Williams CN
    Can J Gastroenterol; 1999 Oct; 13(8):639-40. PubMed ID: 10545649
    [No Abstract]   [Full Text] [Related]  

  • 6. [Percutaneous liver biopsy in diabetics--experiences between 1968 and 1971].
    Schmidt R; Tennstedt A
    Z Arztl Fortbild (Jena); 1974 Mar; 68(6):298-302. PubMed ID: 4418773
    [No Abstract]   [Full Text] [Related]  

  • 7. [NASH -- nonalcoholic steatohepatitis].
    Blechacz B; Stremmel W
    Z Gastroenterol; 2003 Jan; 41(1):77-90. PubMed ID: 12541180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease.
    Nobili V; Carpino G; Alisi A; Franchitto A; Alpini G; De Vito R; Onori P; Alvaro D; Gaudio E
    Hepatology; 2012 Dec; 56(6):2142-53. PubMed ID: 22467277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathology of diabetic hepatitis.
    Nagore N; Scheuer PJ
    J Pathol; 1988 Oct; 156(2):155-60. PubMed ID: 3199264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone trial for NASH: results show promise.
    Lang L
    Gastroenterology; 2007 Mar; 132(3):836-8. PubMed ID: 17383411
    [No Abstract]   [Full Text] [Related]  

  • 11. Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient.
    Carson K; Washington MK; Treem WR; Clavien PA; Hunt CM
    Liver Transpl Surg; 1997 Mar; 3(2):174-6. PubMed ID: 9346732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty liver, alcoholic hepatitis and cirrhosis produced by alcohol in primates.
    Rubin E; Lieber CS
    N Engl J Med; 1974 Jan; 290(3):128-35. PubMed ID: 4202520
    [No Abstract]   [Full Text] [Related]  

  • 13. [Steatosis and cirrhosis secondary to insulin resistance in children. Possible physiopathological mechanisms].
    Bonet Serra B; Barrio Merino A; Quintanar Rioja A; Alavés Buforn M; Nevado Santos M
    An Esp Pediatr; 2002 Apr; 56(4):353-6. PubMed ID: 11927081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipokines and liver fibrosis.
    Marra F; Aleffi S; Bertolani C; Petrai I; Vizzutti F
    Eur Rev Med Pharmacol Sci; 2005; 9(5):279-84. PubMed ID: 16231590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-alcoholic steatohepatitis: a controversial cause of liver cirrhosis].
    Guilarte López-Mañas J; Bellot García V; Gil Villa MM
    Gastroenterol Hepatol; 1997 Apr; 20(4):217. PubMed ID: 9280618
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nonalcoholic steatohepatitis. Three case reports].
    Eivindson MV; Hamilton-Dutoit S; Grønbaek H
    Ugeskr Laeger; 2003 Mar; 165(11):1118-20. PubMed ID: 12677986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non alcoholic steatohepatitis].
    Manero E; Findor JA; Avagnina A; de Elizalde S; Elsner B
    Medicina (B Aires); 1994; 54(6):625-9. PubMed ID: 7658998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C.
    Solis-Herruzo JA; Pérez-Carreras M; Rivas E; Fernández-Vázquez I; Garfia C; Bernardos E; Castellano G; Colina F
    Am J Gastroenterol; 2005 May; 100(5):1091-8. PubMed ID: 15842583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis.
    Satapathy SK; Sakhuja P; Malhotra V; Sharma BC; Sarin SK
    J Gastroenterol Hepatol; 2007 May; 22(5):634-8. PubMed ID: 17444848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic steatohepatitis and cancer.
    Bugianesi E
    Clin Liver Dis; 2007 Feb; 11(1):191-207, x-xi. PubMed ID: 17544979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.